Possible role of rivoglitazone thiazolidine class of drug as dual-target therapeutic agent for bacterial infections: An in silico study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Possible role of rivoglitazone thiazolidine class of drug as dual-target therapeutic agent for bacterial infections: An in silico study

Published:2019-10 Issue: Volume:131 Page:109305
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Yele Vidyasrilekha,Saha Niladri,Md Afzal Azam

Publisher

Elsevier BV

Subject

General Medicine

Reference46 articles.

1. Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections;Li;J Orthop Res,2018

2. The crisis in antibiotic resistance;Neu;Science,1992

3. Ready for a world without antibiotics? The pensières antibiotic resistance call to action;Carlet;BioMed Central,2012

4. Molecular mechanisms of antibiotic resistance;Blair;Nat Rev Microbiol,2015

5. Bacterial resistance to antibiotics: modified target sites;Lambert;Adv Drug Deliv Rev,2005

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypothesis validation of rosiglitazone a potential inhibitor against glycogen synthase kinase-3β, for the management of multifaceted pathophysiology of the diabetic wound: An insilico study;Medical Hypotheses;2020-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP